Dr Reddy's Laboratories - 18 Year Stock Split History | RDY

Stock split history for Dr Reddy's Laboratories since 2001. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Dr Reddy's Laboratories Annual Stock Splits
Dr Reddy's Laboratories Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $5.845B $2.225B
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $52.239B 9.53
Mylan (MYL) United Kingdom $9.900B 4.36
Bausch Health Cos (BHC) Canada $7.682B 5.12
Teva Pharmaceutical Industries (TEVA) Israel $7.327B 2.88
ASPEN PHARMACR (APNHY) South Africa $1.922B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.443B 14.11
Amphastar Pharmaceuticals (AMPH) United States $1.044B 51.42
Voyager Therapeutics (VYGR) United States $0.800B 0.00
Homology Medicines (FIXX) United States $0.773B 0.00
CymaBay Therapeutics (CBAY) United States $0.394B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.385B 0.52
Akorn (AKRX) United States $0.359B 0.00
Assembly Biosciences (ASMB) United States $0.327B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.306B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.262B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.172B 0.00
Sol-Gel Technologies (SLGL) Israel $0.160B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.092B 0.00
Teligent (TLGT) United States $0.037B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00